Deepbiome Therapeutics
Jamaica Plain, US · Founded 2016 · Delaware corporation
Founders & leadership
PB
Peter B. FinnNamed on SEC filing
CL
Chengwei LuoNamed on SEC filing
AK
Aleksandar KosticNamed on SEC filing
JL
Jimmy LuNamed on SEC filing
JW
Ji Woong ChunNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 1 round · 2019
▶$2.5MraisedOct 2019 · 7 investors · Other Health CareRule 506(b)
▶$2.5MraisedOct 2019 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter B. FinnExecutive Officer
- Chengwei LuoExecutive Officer, Director
- Aleksandar KosticDirector
- Jimmy LuDirector
- Ji Woong ChunDirector
- Offering amount
- $4.9M
- Amount sold
- $2.5M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Deepbiome Therapeutics raised?
- Deepbiome Therapeutics has disclosed $2.5M raised across 1 round.
- Where is Deepbiome Therapeutics headquartered?
- Deepbiome Therapeutics is headquartered in Jamaica Plain, US.